Faeth Therapeutics, Inc.
FTH
$32.34
$3.7913.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 90.60% | -3,508.99% | -3.26% | 7.46% | 28.09% |
| Total Depreciation and Amortization | -16.67% | -11.76% | 0.00% | -8.11% | 8.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.38% | 27,320.83% | 11.27% | 0.21% | -19.66% |
| Change in Net Operating Assets | -126.43% | 4,557.34% | -39.02% | 131.52% | -73.22% |
| Cash from Operations | -46.03% | -177.77% | -7.75% | 39.31% | 16.70% |
| Capital Expenditure | 100.00% | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | 425.00% |
| Cash Acquisitions | -100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -185.18% | -1,920.95% | 19.39% | -79.64% | 19.75% |
| Cash from Investing | -243.77% | -1,610.62% | 19.39% | -80.10% | 21.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 70.97% | 45.13% | 25.66% | 51.59% | -48.82% |
| Issuance of Common Stock | -90.51% | 51,550.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | 100.00% |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 88.36% | -- | -100.00% | -99.29% | -- |
| Cash from Financing | -100.91% | 167,510.81% | 26.97% | 9.52% | 21.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.31% | 7,684.85% | 5.06% | -174.44% | 2,390.60% |